Computed tomography-guided chemical renal sympathetic nerve modulation in the treatment of resistant hypertension: A case report

Table 1 Evaluation of the measurements of blood pressure, drugs and complications

Time intervals	Blood pressure (mmHg)			Heart rate (bpm)	Antihypertensive drugs	Complications
	SP	DP	MBP
Pre-3 d1	178	74	109	87	Valsartan 80 mg; hydrochlorothiazide; 12.5 mg; amlodipine besylate 10 mg	Headache
Operation	117	60	79	65	None	None
Post-1 d	133	62	86	71	Valsartan 80 mg; hydrochlorothiazide; 12.5 mg; amlodipine besylate 10 mg	None
Post-2 d	151	69	96	73	Valsartan 80 mg; hydrochlorothiazide; 12.5 mg; amlodipine besylate 10 mg	None
Post-3 d	143	66	92	76	valsartan 80 mg; hydrochlorothiazide; 12.5 mg; amlodipine besylate 10 mg	None
Post-1 yr	137	65	89	69	Amlodipine besylate 10 mg	None
Post-2 yr	134	64	87	73	Amlodipine besylate 10 mg	None
Post-3 yr	145	71	96	77	Amlodipine besylate 10 mg	None
Post-4 yr	145	64	91	74	None	None

¹Blood pressure and use of drugs 3 d before the operation were regarded as baseline. SP: Systolic pressure; DP: Diastolic pressure; MBP: Mean blood pressure.